--- title: Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test description: Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. image: https://www.oliverhcp.com/hubfs/01%20Blog%20Thumbs/eli%20lilly.jpg --- [Skip to Main Content](https://www.oliverhcp.com/news-and-resources/packtalk/eli-lilly-starts-human-study-of-potential-covid-19-antibody-test#main-content) Language ![](https://www.oliverhcp.com/hubfs/down_arrow.svg) English ESPAÑOL DEUTSCH FRANÇAIS 日本語 한국어 中文 - [PackTalk ](https://www.oliverhcp.com/packtalk/) - [ISO Certifications & Product Documents ](https://www.oliverhcp.com/iso-certifications-and-product-documents) [![Oliver_Logo_4clr_RGB_NoTag 1](https://www.oliverhcp.com/hubfs/Oliver_Logo_4clr_RGB_NoTag%201.svg "Oliver_Logo_4clr_RGB_NoTag 1")](https://oliverhcp.com) Toggle Menu Search Site Search Site Search [ Contact Us ](https://www.oliverhcp.com/contact) Phone Close **Website Settings** - No Animations [![](https://www.oliverhcp.com/hubfs/Oliver-logo-half.svg) ](https://www.oliverhcp.com/) [![](https://www.oliverhcp.com/hubfs/phone.svg) 833.465.4837](tel:833.465.4837) Language ![](https://www.oliverhcp.com/hubfs/down_arrow.svg) ENGLISH 中文 ESPAÑOL DEUTSCH FRANÇAIS 日本語 한국어 [PackTalk](https://www.oliverhcp.com/packtalk/) SEARCH![](https://www.oliverhcp.com/hubfs/icon-search.svg) #### Expanded Stock Pouch Program ![](https://www.oliverhcp.com/hubfs/43.png) Expedited shipping from a partner you trust, now with more pouch options in a variety of sizes and materials. Don't let long lead times hold you back. Let Oliver help. [Learn More](https://www.oliverhcp.com/stockpouchprogram) [![logo-pack-talk-2](https://www.oliverhcp.com/hubfs/logo-pack-talk-2.svg) ](https://www.oliverhcp.com/packtalk/) # Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test Oliver Healthcare Packaging Published on: 06/04/2020 Share:  [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/sharing/share-offsite/?url=https://www.oliverhcp.com/news-and-resources/packtalk/eli-lilly-starts-human-study-of-potential-covid-19-antibody-test) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/sharer/sharer.php?u=https://www.oliverhcp.com/news-and-resources/packtalk/eli-lilly-starts-human-study-of-potential-covid-19-antibody-test) [![](https://www.oliverhcp.com/hubfs/Email%20Icon.svg)](mailto:?subject=I%20wanted%20to%20share%20this%20great%20article&body=The%20article%20I%20wanted%20to%20share%20-%20https://www.oliverhcp.com/news-and-resources/packtalk/eli-lilly-starts-human-study-of-potential-covid-19-antibody-test) ![eli lilly](https://www.oliverhcp.com/hubfs/01%20Blog%20Thumbs/eli%20lilly.jpg?quality=low) Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. Eli Lilly is anticipating results to their study by end of June. Read more about the treatment [here](https://www.reuters.com/article/us-health-coronavirus-lilly-treatments-idUSKBN23825Y). Share:  [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/sharing/share-offsite/?url=https://www.oliverhcp.com/news-and-resources/packtalk/eli-lilly-starts-human-study-of-potential-covid-19-antibody-test) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/sharer/sharer.php?u=https://www.oliverhcp.com/news-and-resources/packtalk/eli-lilly-starts-human-study-of-potential-covid-19-antibody-test) [![](https://www.oliverhcp.com/hubfs/Email%20Icon.svg)](mailto:?subject=I%20wanted%20to%20share%20this%20great%20article&body=The%20article%20I%20wanted%20to%20share%20-%20https://www.oliverhcp.com/news-and-resources/packtalk/eli-lilly-starts-human-study-of-potential-covid-19-antibody-test) ## Stay up to date with PackTalk! FOLLOW US: [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/company/oliverhealthcarepackaging) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/oliverhcp/) [![](https://www.oliverhcp.com/hubfs/Content%20Hub/youtube.svg)](https://www.youtube.com/channel/UCzbJZ9TG2QK46F_EV-szUMg) ## Recently Published Articles [![](https://www.oliverhcp.com/hubfs/seal%20creep%20blog.png) ](https://www.oliverhcp.com/news-and-resources/packtalk/investigating-seal-creep-looking-beyond-the-packaging) ### [Investigating Seal Creep: Looking Beyond the Packaging](https://www.oliverhcp.com/news-and-resources/packtalk/investigating-seal-creep-looking-beyond-the-packaging) Lee Hyland ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Education Regulations and Standards  — 2 minute read [![](https://www.oliverhcp.com/hubfs/megan%20blog%206-23.jpg) ](https://www.oliverhcp.com/news-and-resources/packtalk/preventing-packaging-failures-with-hdpe-cards) ### [Preventing Packaging Failures with HDPE Cards](https://www.oliverhcp.com/news-and-resources/packtalk/preventing-packaging-failures-with-hdpe-cards) Christian Packard ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Regulations and Standards  — 2 minute read [![](https://www.oliverhcp.com/hubfs/Blog%20Image%20%286%29.png) ](https://www.oliverhcp.com/news-and-resources/packtalk/australias-unique-device-identification-framework) ### [Australia’s Unique Device Identification Framework](https://www.oliverhcp.com/news-and-resources/packtalk/australias-unique-device-identification-framework) Beryl Choo ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Regulations and Standards Medical Device  — 3 minute read ## Contact Us ![](https://www.oliverhcp.com/hubfs/icon-mail-alt.svg) CONTACT US CHAT ![](https://dc.ads.linkedin.com/collect/?pid=94507&fmt=gif)